Provided are topical pharmaceutical compositions including fatty acid bile acid conjugates (FABACs) as an active ingredient. Further provided are methods of using pharmaceutical compositions comprising FABACs for treating skin conditions associated with altered sebum levels, including but not limited to, acne.